Eckelman Living Trust Dated February 5, 2014, 10% Owner at Inhibrx, Inc. (INBX), sold 400 shares at $25.04 ($10K) on 2022-04-05, disclosed to the SEC on 2022-04-07.
Scheduled sale ($10k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INBX | SELL | 2021-02-18 | $440K | — | Filing → |